Back to
FARALLON CAPITAL MANAGEMENT, L.L.C.
TNGX14 quarters
Position history for
FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in Tango Therapeutics, Inc.
FARALLON CAPITAL MANAGEMENT, L.L.C. holds 12.3M shares of TNGX (Tango Therapeutics, Inc.), worth $383.8M as of 2026-Q2. The position was increased (+35.0% shares). TNGX represents 1.8% of FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio.
Current Value
$383.8M
Current Shares
12.3M
Total Value Change
+$379.9M
Total Shares Change
+12M
Quarter-by-Quarter History
Other major holders of TNGX: RTW INVESTMENTS, LP, BlackRock, Inc., FMR LLC, GOLDMAN SACHS GROUP INC